These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25592893)

  • 1. Priorities in Ebola research--a view from the field.
    Boyles T
    Lancet; 2015 Jan; 385(9962):23. PubMed ID: 25592893
    [No Abstract]   [Full Text] [Related]  

  • 2. First trials for Ebola treatments announced.
    Mohammadi D
    Lancet; 2014 Nov; 384(9957):1833. PubMed ID: 25478606
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ebola and favipiravir: when political preempts scientific communication].
    Nau JY
    Rev Med Suisse; 2015 Mar; 11(464):574-5. PubMed ID: 25924254
    [No Abstract]   [Full Text] [Related]  

  • 4. Infectious diseases. Ebola drug trials lurch ahead.
    Kupferschmidt K; Cohen J
    Science; 2015 Feb; 347(6223):701-2. PubMed ID: 25678637
    [No Abstract]   [Full Text] [Related]  

  • 5. Favipiravir for children with Ebola.
    Bouazza N; Treluyer JM; Foissac F; Mentré F; Taburet AM; Guedj J; Anglaret X; de Lamballerie X; Keïta S; Malvy D; Frange P
    Lancet; 2015 Feb; 385(9968):603-604. PubMed ID: 25706078
    [No Abstract]   [Full Text] [Related]  

  • 6. A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea.
    Palich R; Gala JL; Petitjean F; Shepherd S; Peyrouset O; Abdoul BM; Kinda M; Danel C; Augier A; Anglaret X; Malvy D; Blackwell N;
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004393. PubMed ID: 27011342
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of Ebola therapies to begin in December.
    Gulland A
    BMJ; 2014 Nov; 349():g6827. PubMed ID: 25398534
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.
    Zhang T; Zhai M; Ji J; Zhang J; Tian Y; Liu X
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2364-2368. PubMed ID: 28462833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.
    Carazo Perez S; Folkesson E; Anglaret X; Beavogui AH; Berbain E; Camara AM; Depoortere E; Lefevre A; Maes P; Malme KN; Malvy JD; Ombelet S; Poelaert G; Sissoko D; Tounkara A; Trbovic P; Piguet P; Antierens A
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005545. PubMed ID: 28640812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favipiravir: a new medication for the Ebola virus disease pandemic.
    Nagata T; Lefor AK; Hasegawa M; Ishii M
    Disaster Med Public Health Prep; 2015 Feb; 9(1):79-81. PubMed ID: 25544306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.
    Chinello P; Petrosillo N; Pittalis S; Biava G; Ippolito G; Nicastri E;
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006034. PubMed ID: 29283993
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporary neurocognitive impairment with Ebola virus.
    Nicastri E; Balestra P; Ricottini M; Petrosillo N; Di Caro A; Capobianchi MR; Giancola ML; Ippolito G;
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1386-1387. PubMed ID: 27435087
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of chemically synthesized inhibitors of Ebola virus.
    Cardile AP; Mayers DL; Bavari S
    Recent Pat Antiinfect Drug Discov; 2014; 9(2):97-103. PubMed ID: 25808170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favipiravir--a prophylactic treatment for Ebola contacts?
    Van Herp M; Declerck H; Decroo T
    Lancet; 2015 Jun; 385(9985):2350. PubMed ID: 26088635
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
    PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola.
    Caluwaerts S
    Reprod Health; 2017 Dec; 14(Suppl 3):157. PubMed ID: 29297408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.
    Bai CQ; Mu JS; Kargbo D; Song YB; Niu WK; Nie WM; Kanu A; Liu WW; Wang YP; Dafae F; Yan T; Hu Y; Deng YQ; Lu HJ; Yang F; Zhang XG; Sun Y; Cao YX; Su HX; Sun Y; Liu WS; Wang CY; Qian J; Liu L; Wang H; Tong YG; Liu ZY; Chen YS; Wang HQ; Kargbo B; Gao GF; Jiang JF
    Clin Infect Dis; 2016 Nov; 63(10):1288-1294. PubMed ID: 27553371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.
    Shantha JG; Crozier I; Varkey JB; Kraft CS; Lyon GM; Mehta AK; Carlson RD; Hill CE; Kumar G; Debiec MR; Patel PS; Olsen TW; Nussenblatt RB; Martin DF; Ströher U; Uyeki TM; Ribner BS; Smith JR; Yeh S
    Ophthalmology; 2016 Dec; 123(12):2626-2628.e2. PubMed ID: 27594198
    [No Abstract]   [Full Text] [Related]  

  • 20. Early and repeated use of plasma for the management of Ebola patients: Reflection around a case.
    Dufour-Gaume F; Delaune D; Martinaud C; Sailliol A
    Transfus Clin Biol; 2017 Feb; 24(1):5-8. PubMed ID: 27640108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.